NovaBone Adds to Line of Bone Graft Products

Medical device company NovaBone Products LLC of Jacksonville, Fla., has rolled out two new bone graft products based on the combination of bioactive glass and bovine collagen.

MacroFORM Packable Graft combines 85 percent bioactive ingredient with collagen in a mixing cup while MacroFORM Composite combines 90 percent bioactive ingredient with collagen in a preformed strip. According to company officials, MacroFORM’s highly bioactive collagen scaffold is engineered to have an open porous structure to enhance the absorption of bone marrow aspirate and facilitate bone growth.

Both products can be manipulated into a putty format after mixing.

“Since its inception, our company has developed numerous formulations and delivery systems that accelerated bone growth,” said Arthur Wotiz, president of NovaBone Products. “We are especially proud of this collagen based product and will continue to pioneer collagen grafting options.”

MacroFORM’s research and development plan was designed to achieve a high weight percent of active ingredient while developing robust manufacturing processes, according to the company. With the success of this effort, NovaBone now has a defined core competence in designing and manufacturing collagen products with research underway for additional formulations.

NovaBone’s primary product, eponymously named NovaBone, was the first bioactive synthetic bone graft offered to the orthopedic community, the company claims. The unique properties of the product formulation gave rise to the need to scientifically define its bone-forming process, and in 2005, the U.S. Food and Drug Administration authorized the term “osteostimulation,” as a way to describe how the company’s products signal genetic pathways to accelerate natural regeneration of bone.

NovaBone Products makes a number of formulations and delivery systems of products used in orthopedic and dental surgeries.